Opko

360Dx Top 30 Inches Up in May After April Plummet

In Brief This Week: Labcorp, Lucid Diagnostics, Seegene, Babson Diagnostics, Danaher, More

Opko Health Q1 Revenues Slide 40 Percent on Lower COVID Testing Volume

360Dx Top 30 Falls Slightly in March

Opko Health Posts 19 Percent Drop in Q4 Revenues on COVID-19 Testing Decline

Sema4 to Acquire GeneDx for $623M

JP Morgan Healthcare Conference Day 3: Quest Diagnostics, Exact Sciences, Quidel, More

360Dx Index Grows 4 Percent in December Alongside Broader Markets

FDA Approves Opko Health 4KScore Prostate Cancer Test

Opko Health Q3 Revenues Fall 10 Percent

360Dx Index Maintains Steady Ascent, Increasing 3 Percent in August

In Brief This Week: FIND, Sophia Genetics, Dante Labs, BioReference Laboratories, and More

Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent

In Brief This Week: PerkinElmer, Qiagen, BioReference Laboratories, AstraZeneca, and More

Opko Health Q1 Revenues More Than Double Due to COVID-19 Test Demand

BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB

Opko Health Q4 Revenues More Than Double Thanks to COVID-19 Testing

In Brief This Week: BioReference Laboratories, PerkinElmer, Fluidigm, Invitae, and More